GALT stock forecast
Our latest prediction for Galectin Therapeutics, Inc.'s stock price was made on the May 31, 2019 when the stock price was at 4.03$.
In the short term (2weeks), GALT's stock price should outperform the market by 5.27%. During that period the price should oscillate between -7.72% and +13.34%.
In the medium term (3months), GALT's stock price should outperform the market by 1.82%. During that period the price should oscillate between -19.70% and +34.87%.Get email alerts
Create a solid portfolio with GALT
About Galectin Therapeutics, Inc.
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease and cancer. Its programs target the development of carbohydrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.35$ per share.
The book value per share is 0.02$
Three months stock forecastMay 31, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|